Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in New York

If you’re a psychiatrist or psychiatric mental health nurse practitioner thinking about how to prescribe medications effectively—especially via telehealth—you’re navigating one of the most complicated and rapidly evolving areas of healthcare regulation. Between federal DEA waivers, state-specific scope of practice laws, and telehealth prescribing rules that vary wildly, it’s easy to feel like you need a law degree just to write a prescription.

Here’s the reality: prescribing psychiatric medications, including controlled substances, is more accessible via telehealth in 2026 than ever before—but the rules depend heavily on where you practice, what credentials you hold, and which medications you’re prescribing. This guide breaks down what psychiatrists and PMHNPs can actually do, state by state, and how telehealth platforms like Klarity Health simplify compliance while you focus on patient care.

The Big Picture: Psychiatrists vs PMHNPs in Prescribing Authority

Let’s start with the fundamental divide:

Psychiatrists (MD/DO) have full, unrestricted prescribing authority in all 50 states. You can prescribe any psychiatric medication—antidepressants, antipsychotics, stimulants for ADHD, benzodiazepines, buprenorphine for opioid use disorder—without physician oversight, collaborative agreements, or state-mandated supervision. Your only requirements are maintaining your state medical license and DEA registration for controlled substances.

Psychiatric Mental Health Nurse Practitioners (PMHNPs), on the other hand, face a patchwork of state laws that range from full independence to strict physician supervision requirements. As of 2025, approximately 34 states grant NPs Full Practice Authority (FPA), meaning experienced PMHNPs can evaluate, diagnose, and prescribe independently. But in the remaining states—including major markets like Texas, Florida, and Pennsylvania—PMHNPs must work under collaborative agreements with physicians, often with explicit limitations on controlled substance prescribing.

This creates real pain points for PMHNPs practicing telehealth across multiple states. You might have full autonomy in Illinois after meeting your 4,000-hour requirement, but if you want to see patients in Texas, you’ll need a supervising physician there—and Texas law prohibits NPs from prescribing most Schedule II controlled substances in outpatient settings, which directly impacts ADHD treatment.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Controlled Substance Prescribing via Telehealth: What’s Legal in 2026?

This is the question every psychiatric prescriber asks: Can I prescribe Adderall, Xanax, or Suboxone via a video visit?

The short answer is yes—for now—thanks to federal DEA waivers that have been extended through December 31, 2025. The Ryan Haight Act normally requires an initial in-person exam before prescribing controlled substances, but COVID-era emergency flexibilities waived that requirement. As of early 2026, those waivers remain in effect, meaning psychiatrists nationwide can initiate controlled substance prescriptions (including Schedule II stimulants for ADHD) via telehealth without ever seeing the patient in person.

However, providers must stay alert: the DEA has proposed new permanent rules that could re-impose some in-person requirements (potentially with exceptions for 30-day initial supplies or physician referrals). Until those rules are finalized—expected by late 2024 but still pending—the current flexibilities continue.

State-Specific Controlled Substance Rules

While federal law sets the baseline, states can impose additional restrictions:

Florida is notably permissive: state law explicitly allows teleprescribing of controlled substances for psychiatric treatment (Florida Statutes §456.47). A Florida-licensed psychiatrist can initiate stimulants or benzodiazepines for mental health conditions via telemedicine—something that’s prohibited in Florida for chronic pain management. Florida even carved out an exception for ‘psychiatric nurses’ (PMHNPs with 2+ years of experience under a psychiatrist) to prescribe psychotropic controlled substances beyond the usual 7-day limit for Schedule II drugs.

Texas prohibits teleprescribing of Schedule II controlled substances for chronic pain (must be in-person), but allows it for psychiatric treatment under federal waivers. Texas psychiatrists can prescribe ADHD stimulants via telehealth, but must check the state Prescription Monitoring Program (PMP) before every controlled substance prescription. For PMHNPs in Texas, the situation is more restrictive: state law generally prohibits NPs from prescribing Schedule II drugs in outpatient settings (except terminal illness cases), though there’s a narrow exception for pediatric ADHD treatment. In practice, many Texas telehealth platforms have supervising psychiatrists write the initial stimulant prescriptions, then NPs manage Schedule III-V medications.

New York recently aligned its state rules with federal telehealth allowances. In mid-2025, NYSDOH finalized regulations removing state-level obstacles to controlled substance teleprescribing when consistent with DEA waivers. New York psychiatrists can now prescribe controlled meds via telehealth without state-level non-compliance concerns. One quirk: New York requires e-prescribing for all controlled substances (no paper scripts) and mandates checking the I-STOP PMP registry before prescribing any Schedule II-IV drug.

California doesn’t require in-person exams for prescribing—telehealth evaluations satisfy the ‘good faith exam’ standard under state law. California psychiatrists can prescribe controlled substances via video visits during the federal waiver period. Providers must enroll in CURES (California’s PMP) and check it at least every 4 months for ongoing controlled substance therapy.

Pennsylvania and Illinois generally default to federal law on controlled substance prescribing. Both allow teleprescribing under DEA waivers, with PMP check requirements (Pennsylvania requires reviewing 10% of charts for NP collaborative agreements; Illinois requires separate controlled substance registration for NPs with FPA).

PMHNP Scope of Practice: The State-by-State Reality

For psychiatric nurse practitioners, understanding your state’s scope of practice isn’t just regulatory compliance—it’s fundamental to whether you can actually practice independently or need to find (and often pay for) a collaborating psychiatrist.

Full Practice Authority States

In Full Practice Authority (FPA) states, experienced PMHNPs can practice independently without physician oversight. As of 2025, about 34 states plus DC grant FPA, including states like Washington, Oregon, Arizona, Colorado, and Minnesota that have had it for years.

New York allows PMHNPs to practice independently after completing 3,600 hours (roughly 2 years) under a collaborative agreement. Once you hit that threshold and file an attestation with the state Department of Education, you no longer need a written agreement or supervisor—just an informal ‘collaborative relationship’ with physicians for consultation. This means a PMHNP with a couple years of experience in New York can prescribe independently just like a psychiatrist.

Illinois requires 4,000 hours of supervised practice plus 250 hours of continuing education in advanced pharmacology before granting Full Practice Authority. Until you achieve FPA licensure, you must have a Written Collaborative Agreement with a physician, and technically your prescriptions list the collaborating physician’s name to signal delegation. Once you have FPA, you can prescribe controlled substances independently (after applying for a mid-level controlled substance license).

California is transitioning to FPA via a two-step process under AB 890. Starting January 2023, NPs with ≥3 years of experience could become ‘103 NPs’ and practice without physician supervision in collaborative settings (like clinics with physicians on staff). By January 1, 2026, experienced NPs can apply to become ‘104 NPs’ with full independent practice authority even outside group settings. New graduate NPs still need physician-supervised standardized procedures for at least 3 years. By 2026, California will effectively be a Full Practice state for experienced PMHNPs.

Restricted/Reduced Practice States

Texas remains one of the most restrictive states for NP practice. PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician for any prescribing. There is no pathway to independence—all NPs, regardless of experience, need a collaborator indefinitely. Texas law also limits one physician to supervising no more than 7 NPs/PAs simultaneously, and requires monthly face-to-face meetings for the first 3 years of an agreement, then quarterly thereafter.

The Schedule II restriction is particularly challenging: Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (except for terminal illness or emergency situations). For ADHD treatment in telehealth, this often means the supervising psychiatrist writes the initial Adderall prescription, while the NP manages follow-ups with Schedule III-V medications or non-controlled alternatives.

Florida created an ‘Autonomous APRN’ category in 2020, but explicitly excluded psychiatric NPs. Only family medicine, pediatrics, and internal medicine NPs can practice autonomously in Florida. PMHNPs must still practice under a supervising physician’s protocol. However, Florida does allow ‘psychiatric nurses’ (PMHNPs with 2+ years of experience under a psychiatrist) to prescribe psychotropic controlled substances for mental illness treatment, with the 7-day Schedule II limit waived for psychiatric medications. Legislation to extend autonomous practice to psychiatric NPs (HB 771) has been introduced but not enacted as of 2025.

Pennsylvania requires all NPs to maintain a collaborative agreement indefinitely—there’s no experience threshold that grants independence. The agreement must specify which drugs the NP can prescribe, and Schedule II prescriptions are limited to 30-day supplies with physician notification within 24 hours. Pennsylvania requires physicians to countersign a certain percentage of NP charts (often 10%) and meet at least twice yearly. Legislation to grant FPA has passed the PA Senate but stalled in the House; until it passes, PMHNPs remain under supervised practice.

Collaborative Agreements: What They Actually Require

In states requiring collaboration, the specifics of your collaborative practice agreement directly affect your ability to practice. These agreements typically include:

Scope Definition: The agreement must list your authorized duties and prescriptive authority. For psychiatric practice, this means specifying which medications you can prescribe and any limitations. Some agreements might state the NP can prescribe medications for adults only, or exclude certain classes like Schedule II stimulants for pediatric patients.

Physician Availability: Most states require the collaborating physician to be available for consultation (usually by phone) and specify response times. If you’re practicing telehealth across multiple states, you might need different collaborating physicians in each restricted state—and they must be licensed in that state.

Chart Review: Many states mandate periodic chart audits. South Carolina requires physicians to review at least 10% of NP charts monthly. Tennessee requires on-site physician visits periodically. Texas doesn’t specify a percentage but requires documentation of quality assurance meetings where cases are reviewed.

Prescription Limitations: The collaborating physician can impose restrictions beyond state law. For example, an agreement might limit the NP to prescribing only non-controlled psychiatric medications, or require physician consultation before starting any benzodiazepine. In Florida and Texas, controlled substance prescribing by an NP must be explicitly delegated in the agreement.

Filing Requirements: Some states (like Kentucky) require filing the collaborative agreement with the state board. Others mandate updates whenever the NP adds a practice site or changes collaborating physicians—a real headache for telehealth providers working with multiple platforms.

The Cost of Collaboration

Finding a collaborating psychiatrist isn’t just a regulatory hurdle—it’s often a financial one. Many physicians charge PMHNPs $1,000-$3,000+ monthly to serve as their collaborator, particularly in high-demand specialties like psychiatry. For early-career NPs trying to build a practice, this can be a significant barrier. Some telehealth platforms (including Klarity Health) solve this by providing collaborating physicians as part of their provider infrastructure, removing that burden entirely.

Reimbursement: What Med Management Actually Pays

Understanding reimbursement is crucial for practice sustainability. Here’s what psychiatric medication management visits actually pay in 2026:

Medicare Rates (National Average)

• 90792 (Initial psychiatric evaluation with medical services, ~60 min): $173
• 99213 (15-minute follow-up med check, established patient): $92-$96
• 99214 (25-minute follow-up or moderate complexity): $125-$136
• 99215 (40-minute visit or high complexity): $192

PMHNPs are reimbursed at 85% of these rates when billing under their own NPI. So a 15-minute med check that pays a psychiatrist $95 pays an NP $81. However, if an NP’s service is billed ‘incident to’ a physician (in-office under direct supervision), it could be paid at 100%—though this doesn’t apply to telehealth since the physician isn’t physically supervising.

Private Insurance

Commercial rates vary widely by region and insurer but often exceed Medicare. In high cost-of-living areas, a major insurer might pay $150 for a 99213 and $200 for a 99214—significantly better than Medicare’s $95 and $136.

Telehealth parity laws in over 40 states require that insurers cover telehealth services at the same rate as in-person visits, particularly for behavioral health. States like Illinois (SB 667) mandate equal reimbursement for telehealth through at least 2027. California (AB 744) requires payment parity for telehealth in contracts after 2021. New York updated its law in 2021 to ensure telehealth reimbursement, though it leaves some flexibility in rate negotiations.

Texas has a private payer law requiring telehealth coverage but doesn’t mandate payment parity—though many Texas insurers voluntarily pay equal rates for tele-mental health given high demand.

Medicaid

Medicaid reimbursement is typically lower than Medicare but often includes enhancements for mental health. Rates vary by state—Florida Medicaid might pay $60-$80 for a 15-minute med check, while states like New York and Pennsylvania have expanded telehealth coverage permanently and pay at parity with in-person visits.

Some state Medicaids also reimburse for audio-only telehealth for mental health (important for populations lacking video access). Medicare extended audio-only coverage for mental health through 2024, paying the same as an office rate when the patient cannot use video.

Collaborative Care Model

The Collaborative Care Model (CoCM) offers new reimbursement streams: Medicare pays about $161 per month for the first CoCM month (99492) and ~$130 for subsequent months (99493) per patient. This applies when a psychiatric consultant works with a primary care team. Some telehealth platforms leverage these codes by having psychiatrists serve as consultants to primary care networks.

The Klarity Health Advantage: Why Platform Economics Beat DIY Marketing

Here’s where most content about starting a psychiatric practice gets it wrong: they quote unrealistically low patient acquisition costs or suggest you can build a thriving telehealth practice with basic SEO and a Google Ads budget.

The reality of DIY patient acquisition:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you factor in click costs, ad testing, and conversion optimization.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers. Zocdoc charges $35-100+ per booking, and total monthly costs including subscription fees add up quickly.
• All-in patient acquisition cost through DIY marketing typically runs $200-500+ per patient when you factor in agency/consultant fees, ad spend testing, staff time to qualify leads, no-show rates from cold leads, and failed campaigns.

Most providers don’t have $3,000-5,000/month to gamble on marketing with uncertain results—especially early in their practice.

Klarity Health’s approach removes that risk entirely:

Instead of paying upfront for marketing and hoping patients show up, you pay a standard listing fee per new patient lead only when a qualified patient books with you. This pay-per-appointment model means:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

Instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels you may not have the expertise to optimize.

For providers handling both psychiatry and prescribing compliance across multiple states, Klarity also handles the licensing complexity: if you’re a PMHNP in a restricted state like Texas or Pennsylvania, Klarity provides collaborating physicians as part of the platform infrastructure. You don’t have to find and pay a collaborator separately—it’s built in.

State-by-State Summary: Quick Reference for Priority States

California

• Psychiatrists: Full independent prescribing
• PMHNPs: Transitioning to independence via AB 890. As of 2023, experienced NPs (103 NP status) can practice in collaborative settings without physician supervision. By Jan 2026, experienced NPs can attain full independence (104 NP)
• Telehealth: CA permits prescribing via telemedicine with a ‘good faith exam’ (video qualifies). Private payers must cover at parity
• Controlled substances: CURES (PMP) check required before prescribing Schedule II-IV

Texas

• Psychiatrists: Full independent prescribing
• PMHNPs: Restricted practice—must have Prescriptive Authority Agreement with TX physician for any prescribing. No independent practice pathway. NPs generally cannot prescribe Schedule II in outpatient settings
• Telehealth: Allows telemedicine prescribing for mental health treatment (not chronic pain). Federal waivers permit controlled substances via telehealth
• Notes: One physician can supervise max 7 NPs. Monthly meetings required first 3 years. 380 mental health HPSAs (614 psychiatrists needed)

Florida

• Psychiatrists: Full independent prescribing
• PMHNPs: Restricted for psych specialty—must practice under supervising physician protocol. ‘Psychiatric nurses’ (2+ years experience) can prescribe psychotropic controlled substances for mental illness with psychiatrist collaboration
• Telehealth: FL explicitly allows teleprescribing of controlled substances for psychiatric treatment. Out-of-state NPs face restrictions
• Notes: 7.8 million Floridians in mental health shortage areas

New York

• Psychiatrists: Full independent prescribing
• PMHNPs: Reduced practice transitioning to FPA after 3,600 hours (~2 years). After threshold, practice independently without written agreement
• Telehealth: Strong telehealth support. 2025 regulations aligned state controlled substance rules with federal DEA waivers
• Notes: E-prescribing required for controlled substances. I-STOP PMP check mandatory before prescribing Schedule II-IV

Pennsylvania

• Psychiatrists: Full independent prescribing
• PMHNPs: Reduced practice—collaborative agreement required indefinitely (no FPA). Schedule II prescriptions limited to 30-day supply with physician notification within 24 hours
• Telehealth: No unique restrictions beyond federal law. Medicaid and major insurers cover telepsychiatry
• Notes: 65 psychiatrist vacancies to eliminate HPSAs. FPA legislation introduced but not passed

Illinois

• Psychiatrists: Full independent prescribing
• PMHNPs: Reduced practice with pathway to FPA after 4,000 hours + 250 CE hours. Until FPA, must have Written Collaborative Agreement
• Telehealth: Strong parity laws—private insurers must reimburse telehealth at parity through 2027 for behavioral health
• Notes: Clinical psychologists with specialized training can prescribe limited formulary under psychiatrist supervision

Practical Takeaways: What This Means for Your Practice

For Psychiatrists:

You have the clearest path to telehealth prescribing. Your only concerns are maintaining state licensure where your patients are located, following DEA requirements, and checking PMPs before prescribing controlled substances. If you’re practicing across multiple states, consider the Interstate Medical Licensure Compact (IMLC) to expedite licensure in member states (Texas, Pennsylvania, and Illinois are members; New York, Florida, and California are not).

For PMHNPs:

Your practice model depends entirely on where you practice:

• In FPA states (or reduced states after meeting hour requirements), you can practice similarly to psychiatrists
• In restricted states, you need either employment under a psychiatrist or a platform that provides collaborating physicians
• For telehealth across multiple states, you need separate licenses AND separate collaborative agreements in each restricted state

For Both:

The economics of patient acquisition strongly favor platform-based models for most providers. Unless you have significant marketing expertise and budget, building patient volume through DIY marketing will cost $200-500+ per patient with months of lead time. Platforms like Klarity Health that use pay-per-appointment models remove upfront risk and provide steady patient flow without requiring you to become a marketing expert.

The regulatory landscape continues evolving rapidly—particularly around telehealth prescribing of controlled substances. Stay current on DEA rule proposals and state legislative changes. What’s legal today might change tomorrow, and vice versa—states are generally moving toward expanded NP scope and permanent telehealth parity, but the timeline varies.

Your Next Steps

If you’re ready to start prescribing via telehealth without the headaches of marketing, compliance management across multiple states, or finding collaborating physicians:

Explore joining Klarity Health’s provider network →

You’ll get access to pre-qualified patients, built-in telehealth infrastructure, and support for multi-state licensing and collaboration requirements—all with a pay-per-appointment model that eliminates upfront marketing risk.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship